CPE and gastrointestinal disease: The insights provided here can be applied to target dimer interfaces with therapeutic molecules that trap or inhibit nascent CpE oligomerization as a means to prevent the building of cytotoxic β-pores, which ultimately could lead to treatments for gastrointestinal diseases induced by CpE.